The Latest Breaking News from AmerisourceBergen

Vanguard stopped buying Russian stocks. AmerisourceBergen said it's still supporting patients in drug trials there

Two big Philadelphia-area companies have taken different paths on their Russia-related businesses this week, as hundreds of firms are pulling business from the country after its invasion of Ukraine.

The Philadelphia Inquirer · Mar 9, 2022

Drug Distributors, JNJ Agree To Settle $26B Opioid Lawsuits

Distributors McKesson Corporation (NYSE: MCK), AmerisourceBergen Corp (NYSE: ABC), Cardinal Health Inc (NYSE: CAH

Benzinga · Feb 25, 2022

Looking Into AmerisourceBergen's Return On Capital Employed

According to Benzinga Pro, during Q1, AmerisourceBergen (NYSE:ABC) earned $449.42 million, a 2.97% increase from the preceding quarter. AmerisourceBergen also posted a total of $59.63 billion in sales, a 1.22% increase since Q4.

Benzinga · Feb 3, 2022

A Preview Of AmerisourceBergen's Earnings

AmerisourceBergen (NYSE:ABC) is set to give its latest quarterly earnings report on Wednesday, 2022-02-02. Here's what investors need to know before the announcement. Analysts estimate that AmerisourceBergen will likely report an Earnings Per Share (EPS) of $2.57.

Benzinga · Feb 1, 2022